GlaxoSmithKline (NYSE:GSK) and Vir Biotechnology (NASDAQ:VIR) have signed a Joint Procurement Agreement with the European Commission (EC) to supply up to 220,000 doses of sotrovimab, an ...

Drugmakers have increasingly put their environmental footprint under a microscope, rolling out power purchase agreements, renewable energy installations and more in a bid to clean up their operations.

Pharmaceutical company GSK launched a sustainable procurement program Sept. 20 in its efforts to reach net-zero impact on the climate. A big chunk of GSK’s carbon emissions, 40 percent, comes from its ...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission (EC) to supply up to 220,000 doses of sotrovimab, an ...

BEIJING/LONDON (Reuters) -China has blocked GSK from participating in its bulk-buy drug procurement programme focused on off-patent medicines from Oct. 31 until April 29, 2024, over quality problems ...

Shanghai’s State Medical Products Administration announced that GSK plc has been banned from participating in volume-based procurement tenders until April 29, 2024, after failing a good manufacturing ...

Pharmaceutical company GlaxoSmithKline has been awarded a $342M contract by the U.S. Army to obtain COVID-19 vaccines in mass quantities from multiple vendors. The service branch obligated the full ...

GlaxoSmithKline (GSK) plans to launch an ecommerce strategy that will enable the global health care company to sell brands like Sensodyne, Polident and Theraflu direct to consumers. The company ...

Commercial-stage immunology company Vir Biotechnology, Inc. (NASDAQ:VIR) recently announced that its SARS-CoV-2 neutralizing monoclonal antibody, developed in collaboration with GlaxoSmithKline, has ...